Like in our results, IGFBP-5 mRNA and protein levels were decreased in a critical IR-related comorbidity: non-alcoholic fatty liver disease (NAFLD) [33]. This evidence concerns the gene IGFBP5 and metabolic dysfunction-associated steatotic liver disease.